Servier Bio Innovation Llc

We track 2 ClinicalTrials.gov studies led by Servier Bio Innovation Llc. The portfolio skews toward Phase 2 (2 trials).

2 clinical trials sponsored by Servier Bio Innovation Llc.

Pipeline by Phase

PhaseTrialsDistribution
Phase 2 2
100%

Trial Status Breakdown

Trials by Servier Bio Innovation Llc

A Phase 1b/2, Multicenter, Open-label Platform Study of Select Immunotherapy Combinations in Adult Participants With Previously Untreated Advanced Non-small Cell Lung Cancer (NSCLC) With High PD-L1 Expression

NCT06162572 · ACTIVE NOT RECRUITING · Phase 2

A Phase 1/2, Open-label, Multicenter Clinical Trial Investigating the Safety, Tolerability, Pharmacokinetics, and Antineoplastic Activity of S095035 (MAT2A Inhibitor) as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors With Homozygous Deletion of MTAP

NCT06188702 · RECRUITING · Phase 2

Frequently Asked Questions

How many clinical trials does Servier Bio Innovation Llc sponsor?

Servier Bio Innovation Llc currently sponsors 2 clinical trials tracked on ReadTheTrial. These span Phase 2.

What conditions does Servier Bio Innovation Llc research?

Servier Bio Innovation Llc conducts research across multiple therapeutic areas. Browse the trial listings for details.

Is Servier Bio Innovation Llc recruiting for clinical trials?

Yes, Servier Bio Innovation Llc currently has 1 trial that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.

Explore More